MétaCan
Menu
Back to cohort

P-103 Refinement of Population Pharmacokinetic Model of Certolizumab Pegol in Crohnʼs Disease Patients to Account for Time Varying Nature of Covariates

2016· article· en· W2326180271 on OpenAlexaff
Niels Vande Casteele, Diane R. Mould, Gordana Kosutic, Marshall Spearman, Brian G. Feagan, William J. Sandborn

Bibliographic record

VenueInflammatory Bowel Diseases · 2016
Typearticle
Languageen
FieldMedicine
TopicMonoclonal and Polyclonal Antibodies Research
Canadian institutionsRobarts Clinical Trials
Fundersnot available
KeywordsNONMEMCertolizumab pegolCovariatePharmacokineticsMedicinePopulationVolume of distributionPopulation pharmacokineticsPercentileInternal medicinePharmacologyStatisticsDiseaseMathematics

Abstract

fetched live from OpenAlex

A population pharmacokinetic (pop PK) analysis for certolizumab pegol (CZP) was developed in patients with Crohn's disease (CD),1 which consisted of a baseline concentration, first-order absorption, and one-compartment disposition. Covariates that influence the disposition of CZP were identified, but only baseline values were used. We subsequently refined the existing model so that time-varying demographic and pathophysiologic characteristics on the estimated variability were taken into account. Data collected from 2157 patients with CD in 9 studies were analyzed using nonlinear mixed effects modeling (NONMEM) software. The CZP concentration-time data were described by a one-compartment pop PK model with first-order absorption and one-compartment disposition with linear, time-dependent elimination. Pop PK estimates, based on the final covariate model, were absorption rate (1.83/day), clearance (CL; 0.527 L/day), and apparent volume of distribution (V; 8.33 L). CZP exhibited interindividual variability for CL of 19.6%. Anti-CZP antibodies were included as a continuous, time-varying covariate on CZP CL in the structural model. CZP CL increased from 142% to 174% for a typical patient with CD over the 5th to the 95th percentile of the anti-CZP antibody range (respectively, 2.5–212.3 units/mL). Covariate analysis showed that time-varying albumin concentration, C-reactive protein concentration, and body weight influenced CZP CL. Female gender was associated with a modest increase in CZP CL. Time-varying body weight influenced CZP V. A pop PK model that takes into account the time-varying nature of patients' covariates reduced the between-patient variability on CZP CL from 27.5%1 to 19.6%, extending learnings from the previous model that included baseline values. By taking into account anti-CZP antibodies as a time-varying and continuous variable in the updated model, future analyses can assess the relative influence of anti-CZP antibodies on CZP CL. This is an important improvement, as inflammatory bowel disease patient covariates are often time-dependent, making this model more reflective of patient drug exposure with sustained treatment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: Simulation or modeling
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.020
Threshold uncertainty score0.039

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.006
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.301
Teacher spread0.287 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueInflammatory Bowel DiseasesSame topicMonoclonal and Polyclonal Antibodies ResearchFrench-language works237,207